Lee's Pharmaceutical Holdings Limited (0950.HK)
HKD 1.32
(0.76%)
HKD 1.32
(0.76%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 298.1 Million HKD | 19.61% |
| 2022 | 249.22 Million HKD | -24.8% |
| 2021 | 331.39 Million HKD | -20.03% |
| 2020 | 414.37 Million HKD | 62.13% |
| 2019 | 255.58 Million HKD | 20.75% |
| 2018 | 211.67 Million HKD | 31.77% |
| 2017 | 160.63 Million HKD | 19.07% |
| 2016 | 134.91 Million HKD | -20.58% |
| 2015 | 169.87 Million HKD | 22.31% |
| 2014 | 138.88 Million HKD | 17.82% |
| 2013 | 117.88 Million HKD | 83.98% |
| 2012 | 64.07 Million HKD | 83.04% |
| 2011 | 35 Million HKD | 51.07% |
| 2010 | 23.17 Million HKD | -13.59% |
| 2009 | 26.81 Million HKD | 290.48% |
| 2008 | 6.86 Million HKD | -19.41% |
| 2007 | 8.52 Million HKD | 109.1% |
| 2006 | 4.07 Million HKD | 8.64% |
| 2005 | 3.75 Million HKD | -3.37% |
| 2004 | 3.88 Million HKD | 75.02% |
| 2003 | 2.21 Million HKD | 153.49% |
| 2002 | 875 Thousand HKD | -5.41% |
| 2001 | 925 Thousand HKD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 FY | 298.1 Million HKD | 19.61% |
| 2023 Q3 | 298.1 Million HKD | -8.3% |
| 2023 Q4 | 298.1 Million HKD | 0.0% |
| 2023 Q1 | 325.09 Million HKD | 30.44% |
| 2023 Q2 | 325.09 Million HKD | 0.0% |
| 2022 Q3 | - HKD | -100.0% |
| 2022 Q4 | 249.22 Million HKD | 0.0% |
| 2022 FY | 249.22 Million HKD | -24.8% |
| 2022 Q1 | - HKD | -100.0% |
| 2022 Q2 | 262.52 Million HKD | 0.0% |
| 2021 FY | 331.39 Million HKD | -20.03% |
| 2021 Q1 | - HKD | -100.0% |
| 2021 Q4 | 331.39 Million HKD | 0.0% |
| 2021 Q2 | 349.5 Million HKD | 0.0% |
| 2020 Q4 | 414.37 Million HKD | 0.0% |
| 2020 Q1 | - HKD | -100.0% |
| 2020 Q2 | 294.1 Million HKD | 0.0% |
| 2020 FY | 414.37 Million HKD | 62.13% |
| 2019 Q1 | - HKD | -100.0% |
| 2019 FY | 255.58 Million HKD | 20.75% |
| 2019 Q2 | 191.99 Million HKD | 0.0% |
| 2019 Q4 | 255.58 Million HKD | 0.0% |
| 2018 Q2 | 150.61 Million HKD | 0.0% |
| 2018 FY | 211.67 Million HKD | 31.77% |
| 2018 Q1 | - HKD | -100.0% |
| 2018 Q4 | 211.67 Million HKD | 0.0% |
| 2017 Q1 | - HKD | -100.0% |
| 2017 FY | 160.63 Million HKD | 19.07% |
| 2017 Q4 | 160.63 Million HKD | 0.0% |
| 2017 Q2 | 149.76 Million HKD | 0.0% |
| 2016 FY | 134.91 Million HKD | -20.58% |
| 2016 Q1 | - HKD | -100.0% |
| 2016 Q2 | 115.19 Million HKD | 0.0% |
| 2016 Q4 | 134.91 Million HKD | 0.0% |
| 2015 FY | 169.87 Million HKD | 22.31% |
| 2015 Q2 | 164.55 Million HKD | 0.0% |
| 2015 Q4 | 169.87 Million HKD | 0.0% |
| 2015 Q1 | - HKD | -100.0% |
| 2014 Q1 | - HKD | -100.0% |
| 2014 Q4 | 138.88 Million HKD | 0.0% |
| 2014 FY | 138.88 Million HKD | 17.82% |
| 2014 Q2 | 98.44 Million HKD | 0.0% |
| 2013 Q1 | - HKD | -100.0% |
| 2013 FY | 117.88 Million HKD | 83.98% |
| 2013 Q4 | 117.88 Million HKD | 0.0% |
| 2013 Q2 | 106.86 Million HKD | 0.0% |
| 2012 FY | 64.07 Million HKD | 83.04% |
| 2012 Q2 | 36.75 Million HKD | 0.0% |
| 2012 Q4 | 64.07 Million HKD | 0.0% |
| 2011 FY | 35 Million HKD | 51.07% |
| 2011 Q2 | 45.7 Million HKD | 0.0% |
| 2011 Q4 | 35 Million HKD | 0.0% |
| 2010 Q2 | 29.1 Million HKD | 0.0% |
| 2010 FY | 23.17 Million HKD | -13.59% |
| 2009 FY | 26.81 Million HKD | 290.48% |
| 2008 FY | 6.86 Million HKD | -19.41% |
| 2007 FY | 8.52 Million HKD | 109.1% |
| 2006 FY | 4.07 Million HKD | 8.64% |
| 2005 FY | 3.75 Million HKD | -3.37% |
| 2004 FY | 3.88 Million HKD | 75.02% |
| 2003 FY | 2.21 Million HKD | 153.49% |
| 2002 FY | 875 Thousand HKD | -5.41% |
| 2001 FY | 925 Thousand HKD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Pak Fah Yeow International Limited | 12.19 Million HKD | -2344.093% |
| Grand Pharmaceutical Group Limited | 1.38 Billion HKD | 78.533% |
| Extrawell Pharmaceutical Holdings Limited | 7.26 Million HKD | -4003.317% |
| Wai Yuen Tong Medicine Holdings Limited | 308.09 Million HKD | 3.243% |
| Qianhai Health Holdings Limited | 431.78 Million HKD | 30.96% |
| Essex Bio-Technology Limited | 62.82 Million HKD | -374.525% |
| Tongfang Kontafarma Holdings Limited | 98.26 Million HKD | -203.366% |
| PuraPharm Corporation Limited | 175.59 Million HKD | -69.767% |
| SSY Group Limited | 1.08 Billion HKD | 72.557% |
| JBM (Healthcare) Limited | 91.58 Million HKD | -225.497% |
| Jacobson Pharma Corporation Limited | 317.85 Million HKD | 6.214% |
| China Resources Pharmaceutical Group Limited | 35.09 Billion HKD | 99.151% |